Sequenom Overview
- Founded
- 1994

- Status
- Acquired/Merged
- Employees
- 434

- Latest Deal Type
- M&A
- Latest Deal Amount
- $371M

Sequenom General Information
Description
Provider of genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides nucleic acid analysis platform that measures genetic target material and variations.
Contact Information
(Operating Subsidiary)
- 3595 John Hopkins Court
- San Diego, CA 92121
- United States
Sequenom Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
18. Merger/Acquisition | 07-Sep-2016 | $371M | 00000 | 00000 | Completed | Profitable |
17. Debt Refinancing | 18-Jun-2015 | 0000 | 00000 | Completed | Profitable | |
16. Debt - General | 20-Sep-2012 | 00000 | 00000 | Completed | Profitable | |
15. 2PO | 25-Jan-2012 | 0000 | 00000 | Completed | Profitable | |
14. Debt - General | 02-Jun-2011 | 0000 | 00000 | Completed | Profitable | |
13. PIPE | 21-May-2010 | 000.00 | 00000 | Completed | Profitable | |
12. PIPE | 23-Dec-2009 | 00.000 | 00000 | Completed | Profitable | |
11. PIPE | 09-Mar-2009 | 00.000 | 00000 | Completed | Profitable | |
10. PIPE | 19-Nov-2008 | $3.6M | $247M | Completed | Profitable | |
9. Secondary Transaction - Open Market | 01-Aug-2008 | $244M | Completed | Profitable |
Sequenom Comparisons
Industry
00000000
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSequenom Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Veracyte | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
0000000 | Private Equity-Backed | Irvine, CA | 000 | 00000 | 000000000 - | 00000 |
000000000000 | Formerly VC-backed | Carlsbad, CA | 000 | 000.00 | 000000&0 | 000.00 |
Sequenom Executive Team (16)
Sequenom Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
Catherine Mackey Ph.D | Self | Board Member | 000 0000 |
Charles Slacik | Sequenom | Director | 000 0000 |
David Pendarvis | Sequenom | Director | 000 0000 |
Dirk van den Boom Ph.D | Sequenom | President, Chief Executive Officer, Board Member, Chief Scientific & Chief Strategy Officer | 000 0000 |
John Fazio | Self | Director | 000 0000 |
Sequenom Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSequenom Former Investors (17)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Comvest Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Delaware Crossing Investor Group | Angel Group | Minority | 000 0000 | 000000 0 | |
Fort Mason Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Global Life Science Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Haspa BGM | PE/Buyout | Majority | 000 0000 | 000000 0 |
Sequenom Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 | 27-Jan-2009 | 000000000000000000 | Biotechnology | 00000 000000 00.0 | |
Sequenom Center for Molecular Medicine | 17-Nov-2008 | Merger/Acquisition | 000 | Laboratory Services (Healthcare) |